Observational study to investigate the intraocular pressure reduction effect by 0.4% Ripasudil after trabectome
Not Applicable
- Conditions
- glaucoma
- Registration Number
- JPRN-UMIN000028066
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have history of allergy to Ripasudil. 2) Patients judged inappropriate at the discretion of the research doctor. 3) Patients complicated of clinically serious diseases.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of intraocular pressure reduction of Ripasudil just before instillation and 2 hours after instillation after trabectome 1 day, 1 week, and 1, 2,3 months
- Secondary Outcome Measures
Name Time Method Effect of intraocular pressure reduction of Ripasudil just before instillation and 2 hours after instillation before trabectome